Cohort Study of the Population Impact of Current and Evolving Treatments for Chronic Hepatitis B and C (CDC-RFA-PS16-002)
Period Length: 5 years
This cooperative agreement supports the development or expansion of the Chronic Hepatitis B and C Cohort Study (CHeCS) – a study observing the same group of patients living with hepatitis B and hepatitis C over time who are receiving clinical care. This model approach is designed to enhance public health knowledge of the effectiveness, costs, benefits, and adverse effects of evolving antiviral therapies and clinical treatments for hepatitis B and hepatitis C on the U.S. population.
CDC has awarded funding for one project in Detroit, Michigan: Henry Ford Health Systems
Funding for the five-year project period is expected to be approximately $300,000 each year.